Canntab Therapeutics Limited Price Patterns
| CTABFDelisted Stock | USD 0.0001 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Canntab Therapeutics hype-based prediction, you can estimate the value of Canntab Therapeutics Limited from the perspective of Canntab Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Canntab Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Canntab because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Canntab Therapeutics after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Canntab |
Canntab Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Canntab Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Canntab Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Canntab Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Canntab Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Canntab Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Canntab Therapeutics' historical news coverage. Canntab Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Canntab Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Canntab Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Canntab Therapeutics is based on 3 months time horizon.
Canntab Therapeutics Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Canntab Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Canntab Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Canntab Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0001 | 0.0001 | 0.00 |
|
Canntab Therapeutics Hype Timeline
Canntab Therapeutics is currently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Canntab is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Canntab Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.1. Canntab Therapeutics last dividend was issued on the 8th of March 2016. The entity had 1:200 split on the 20th of April 2018. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.Canntab Therapeutics Related Hype Analysis
Having access to credible news sources related to Canntab Therapeutics' direct competition is more important than ever and may enhance your ability to predict Canntab Therapeutics' future price movements. Getting to know how Canntab Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Canntab Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| STHZF | StateHouse Holdings | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 9,950 | |
| CNGGF | Cann Group Limited | 0.00 | 0 per month | 0.00 | 0.09 | 5.00 | (1.59) | 265.50 | |
| TGIFF | 1933 Industries | 0.00 | 0 per month | 14.63 | 0.1 | 28.77 | (22.97) | 114.47 | |
| RPNRF | Rapid Nutrition PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LIFD | LFTD Partners | 0.00 | 0 per month | 8.69 | 0.06 | 22.73 | (21.43) | 72.22 | |
| RVVTF | Revive Therapeutics | 0.00 | 0 per month | 11.03 | 0.07 | 31.82 | (22.22) | 93.33 | |
| CPIVF | Captiva Verde Land | 0.00 | 0 per month | 25.46 | 0.23 | 127.27 | (58.95) | 216.41 | |
| TNRG | Thunder Energies Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NRPR | Nutri Pharmaceuticals Research | 0.00 | 0 per month | 0.00 | 0.01 | 0.00 | (12.16) | 129.28 | |
| RNVA | Rennova Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Canntab Therapeutics Additional Predictive Modules
Most predictive techniques to examine Canntab price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Canntab using various technical indicators. When you analyze Canntab charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Canntab Therapeutics Predictive Indicators
The successful prediction of Canntab Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Canntab Therapeutics Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Canntab Therapeutics based on analysis of Canntab Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Canntab Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Canntab Therapeutics's related companies.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Canntab Pink Sheet
If you are still planning to invest in Canntab Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Canntab Therapeutics' history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |